RCT: Safety and efficacy of Daridorexant in patients with insomnia disorder.
25 Jan, 2022 | 09:15h | UTCSafety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials – The Lancet Neurology (link to abstract – $ for full-text)